Western blot analysis of Bcl10 expression in (1) HeLa cell lysate; (2) Raji cell lysate.
| A03157 | |
|
|
|
| ¥37,309.00 | |
|
|
|
|
|
|
| Ask us a question | |
| Specificity | This product is specific to Bcl 10 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Bcl 10 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of Bcl10 expression in (1) HeLa cell lysate; (2) Raji cell lysate.
| Target Background | Plays a key role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation. |
| Synonyms | B cell CLL/lymphoma 10; B-cell leukemia/lymphoma 10; Bcl10; CARD containing molecule enhancing NF kappa B; CARD like apoptotic protein; Caspase recruiting domain containing protein; cE10; Cellular E10; CIPER; hCLAP; Mammalian CARD-containing adapter molecule E10; R-RCD1; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
